CELLECT BIOTECH Company Profile (NASDAQ:APOP)

About CELLECT BIOTECH

CELLECT BIOTECH logo

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: APOP
  • CUSIP:
Key Metrics:
  • Previous Close: $3.76
  • 50 Day Moving Average: $3.18
  • 200 Day Moving Average: $4.01
  • 52-Week Range: $2.30 - $8.78
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -4.49
  • P/E Growth: 0.00
  • Market Cap: $20.55M
  • Outstanding Shares: 5,379,000
Debt:
  • Current Ratio: 4.25%
  • Quick Ratio: 4.25%
Additional Links:
Companies Related to CELLECT BIOTECH:

Analyst Ratings

Consensus Ratings for CELLECT BIOTECH (NASDAQ:APOP) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $10.00 (161.78% upside)

Analysts' Ratings History for CELLECT BIOTECH (NASDAQ:APOP)
Show:
DateFirmActionRatingPrice TargetDetails
11/10/2016Rodman & RenshawInitiated CoverageBuy$10.00View Rating Details
(Data available from 1/21/2015 forward)

Earnings

Earnings History for CELLECT BIOTECH (NASDAQ:APOP)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for CELLECT BIOTECH (NASDAQ:APOP)
Current Year EPS Consensus Estimate: $-0.96 EPS
Next Year EPS Consensus Estimate: $-0.85 EPS

Dividends

Dividend History for CELLECT BIOTECH (NASDAQ:APOP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for CELLECT BIOTECH (NASDAQ:APOP)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for CELLECT BIOTECH (NASDAQ:APOP)
DateHeadline
investing.com logoU.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.03% (NASDAQ:APOP)
www.investing.com - January 13 at 9:06 PM
finanznachrichten.de logoGainers & Losers Of The Day: TBIO, IMMU, SGMO, BIOC, APRI (NASDAQ:APOP)
www.finanznachrichten.de - January 13 at 1:38 AM
tmcnet.com logoCellect Receives Patent Notice of Allowance from US Patent & Trademark Office Protecting Company's Technology in Multiple Key Indications (NASDAQ:APOP)
technews.tmcnet.com - January 12 at 8:38 PM
smarteranalyst.com logoCompany Update (NASDAQ:APOP): Here’s Why Cellect Biotechnology Ltd. – American Depositary Shares Jumped 132% (NASDAQ:APOP)
www.smarteranalyst.com - January 12 at 8:38 PM
rttnews.com logoCellect Biotechnology Ltd. (APOP) Is Surging On Patent News (NASDAQ:APOP)
www.rttnews.com - January 12 at 8:38 PM
us.rd.yahoo.com logoCellect Receives Patent Notice of Allowance from US Patent & Trademark Office Protecting Company’s Technology in Multiple Key Indications (NASDAQ:APOP)
us.rd.yahoo.com - January 12 at 3:37 PM
finance.yahoo.com logoMajor Shareholder Buying Shares (NASDAQ:APOP)
finance.yahoo.com - January 9 at 3:47 PM
seekingalpha.com logoCellect appoints Eyal Leibovitz as CFO (NASDAQ:APOP)
seekingalpha.com - January 4 at 2:13 AM
streetinsider.com logoCellect Biotechnology Ltd. (APOP) Names Eyal Leibovitz as CFO (NASDAQ:APOP)
www.streetinsider.com - January 4 at 2:13 AM
us.rd.yahoo.com logoCellect Announces Appointment of Eyal Leibovitz, Experienced Life Sciences Industry and Financial Executive, as Chief Financial Officer (NASDAQ:APOP)
us.rd.yahoo.com - January 3 at 4:08 PM
us.rd.yahoo.com logo8:04 am Cellect Biotechnology appoints Eyal Leibovitz as CFO (NASDAQ:APOP)
us.rd.yahoo.com - January 3 at 4:08 PM
finance.yahoo.com logoLifeSci Capital Initiates Coverage of Cellect Biotechnology (NASDAQ:APOP)
finance.yahoo.com - December 7 at 9:04 PM
finance.yahoo.com logoCellect Biotechnology Ltd Provides Corporate Update and Reports Third Quarter 2016 Financial Results (NASDAQ:APOP)
finance.yahoo.com - November 29 at 2:38 PM
finance.yahoo.com logoCellect signs agreement with the Hadassah Technological Transfer Company – Hadasit (NASDAQ:APOP)
finance.yahoo.com - November 23 at 12:46 PM
finance.yahoo.com logo10:47 am Cellect Biotechnology (thinly-traded) signs agreement with Hadasit for a series of trials using its ApoGraft method to test engraftment potential and its effect on lowering GvHD in mice models (NASDAQ:APOP)
finance.yahoo.com - November 23 at 12:46 PM
finance.yahoo.com logoCoverage initiated on Cellect Biotechnology by Rodman & Renshaw (NASDAQ:APOP)
finance.yahoo.com - November 10 at 2:02 PM
streetinsider.com logoForm 6-K Cellect Biotechnology For: Sep 26 (NASDAQ:APOP)
www.streetinsider.com - September 26 at 8:16 AM
publicnow.com logoCellect Receives Israeli Ministry of Health Approval to Initiate Phase I/II Clinical Trial in Leukemia Patients (NASDAQ:APOP)
www.publicnow.com - September 20 at 4:39 PM

Social

CELLECT BIOTECH (NASDAQ:APOP) Chart for Saturday, January, 21, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for CELLECT BIOTECH (NASDAQ:APOP)

Earnings History Chart

Earnings by Quarter for CELLECT BIOTECH (NASDAQ:APOP)

Dividend History Chart

Dividend Payments by Quarter for CELLECT BIOTECH (NASDAQ:APOP)

Last Updated on 1/21/2017 by MarketBeat.com Staff